AD5235
81
Although the existing scientific data do not justify FDA
regulatory actions, the FDA has urged the wireless phone
industry to take a number of steps, including the following:
•
Support needed research into possible biological effects
of RF of the type emitted by wireless phones;
•
Design wireless phones in a way that minimizes any RF
exposure to the user that is not necessary for device
function; and
•
Cooperate in providing users of wireless phones with the
best possible information on possible effects of wireless
phone use on human health.
The FDA belongs to an interagency working group of the
federal agencies that have responsibility for different aspects
of RF safety to ensure coordinated efforts at the federal level.
The following agencies belong to this working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency
• Occupational Safety and Health Administration
•
National Telecommunications and Information Administration
The National Institutes of Health participates in some
interagency working group activities, as well.
The FDA shares regulatory responsibilities for wireless
phones with the Federal Communications Commission
(FCC). All phones that are sold in the United States must
comply with FCC safety guidelines that limit RF exposure.
The FCC relies on the FDA and other health agencies for
safety questions about wireless phones.
The FCC also regulates the base stations that the
wireless phone networks rely upon. While these base
stations operate at higher power than do the wireless
SAFETY GUIDELINES
To Next Page
Loading...
